...的同时,也产生较着的全身不良反应如:骨髓抑制、心脏侵害等,临床应用受到限制近年来出现的脂质体阿霉素(Liposome doxorubicin)既能加强药物的抗癌作用,又能削减其毒副作用,逐渐成为卵巢癌疗治的二线药物之一概述自从1 96 5年Bangham发现脂质体后,1971年G...
基于2个网页-相关网页
Doxorubicin Hydrochloride Liposome Injection 多柔比星脂质体注射液 ; 盐酸多柔比星脂质体注射液
doxorubicin liposome 阿霉素脂质体
Doxorubicin hermosensitive liposome 阿素温敏脂质体 ; 阿霉素温敏脂质体
Doxorubicin Hydrochloride Liposome 盐酸多柔比星脂质体注射液
Doxorubicin Hydrochloride Liposome Injec 盐酸多柔比星脂质体注射液
This method has been proved to be simple, sensitive and accurate, and also has been applied to determine sulfate ion in liposome doxorubicin sample with satisfactory results.
用该方法对阿霉素脂质体样品中的微量硫酸根离子进行了分析测定,结果令人满意。
Conclusion: Magnetic doxorubicin stealth liposome, regarding as a new kind carrier of anti-tumor drug, indicated a favorable foreground.
结论:磁性阿霉素隐形脂质体作为一种新型抗肿瘤药物显示了良好的应用前景。
Conclusion Magnetic doxorubicin stealth liposome as a new anti-tumor drug carrier may have a favorable clinical prospect.
结论磁性阿霉素隐形脂质体作为一种新型抗肿瘤药物显示了良好的应用前景。
应用推荐